Li Kang Biomedical Co Ltd Cash Flow Quality Index
Li Kang Biomedical Co Ltd cash flow quality index. Li Kang Biomedical Co Ltd (6242) has a Cash Flow Quality Index of -0.30x as of March 2026. Operating cash flow of NT$-3.17 Million is below net income of NT$10.62 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Li Kang Biomedical Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Li Kang Biomedical Co Ltd (2002–2025)
Cash flow quality index of Li Kang Biomedical Co Ltd from 2002 to 2025. Historical Cash Flow Quality Index for Li Kang Biomedical Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 6242 equity financing ratio to measure how much of total assets are equity-financed.
Li Kang Biomedical Co Ltd Cash Flow Quality Index by Year (2002–2025)
Li Kang Biomedical Co Ltd cash flow quality index by year from 2002 to 2025. Year-by-year earnings quality comparison for Li Kang Biomedical Co Ltd. For the full cash flow conversion analysis, see 6242 cash generation efficiency.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.10x | NT$92.15 Million | NT$83.82 Million | ▲ +29.5% |
| 2024 | 0.85x | NT$65.38 Million | NT$77.02 Million | ▲ +22.1% |
| 2023 | 0.70x | NT$96.74 Million | NT$139.14 Million | ▼ -37.7% |
| 2022 | 1.12x | NT$157.24 Million | NT$140.80 Million | ▲ +17.3% |
| 2021 | 0.95x | NT$60.45 Million | NT$63.48 Million | ▲ +1.4% |
| 2020 | 0.94x | NT$81.67 Million | NT$86.94 Million | ▼ -26.9% |
| 2019 | 1.29x | NT$92.56 Million | NT$72.02 Million | ▼ -6.5% |
| 2018 | 1.38x | NT$105.53 Million | NT$76.74 Million | ▲ +66.3% |
| 2017 | 0.83x | NT$110.61 Million | NT$133.74 Million | ▼ -54.1% |
| 2016 | 1.80x | NT$110.82 Million | NT$61.51 Million | ▲ +49.0% |
| 2015 | 1.21x | NT$63.91 Million | NT$52.85 Million | ▼ -48.7% |
| 2002 | 2.36x | NT$45.87 Million | NT$19.46 Million | — |